News

October 7, 2021

Second Genome Presents Preclinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Demonstrating that a Novel Peptide, SG-3-0020, Upregulates Co-stimulatory and Checkpoint Pathways

September 23, 2021

Second Genome Announces Research Collaboration with Virginia Commonwealth University to Identify a Non-Invasive NASH Composite Biomarker

September 16, 2021

Second Genome Presents Preclinical Data at ESMO 2021 Demonstrating that a Novel Microbiome-Derived Peptide, SG-3-00802, Reverses Resistance to Anti-Programmed Death Protein-1 (PD-1) Therapy

August 23, 2021

Second Genome Announces Milestone Accomplished in Collaboration with Bayer, Demonstrating Broad Application of Company’s Machine Learning Platform to Identify Novel Proteins for the Development of Next-Generation Insect-Control Solutions

August 10, 2021

Second Genome Presents Preclinical Data Demonstrating the Effects of Microbial-Derived Metabolites in Autism Spectrum Disorder

See All News